Novo Nordisk's obesity drug shows weight loss of up to 14.5% in mid-stage study-March 2024-www.financetom.com

Novo Nordisk's obesity drug shows weight loss of up to 14.5% in mid-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk's obesity drug shows weight loss of up to 14.5% in mid-stage study

Nov 25, 2025 3:49 AM

Nov 25 (Reuters) - Novo Nordisk said on

Tuesday its experimental obesity drug, amycretin, showed

statistically significant weight loss of up to 14.5% at 36 weeks

in patients with type 2 diabetes in a mid-stage study.

Previous page： Aug 27 news wrap: From Fed Chair Powell's Jackson Hole address to govt considering IBC committee recommendations Next page： Pay in crypto for your stay at this Swiss luxury hotel

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Aug 27 news wrap: From Fed Chair Powell's Jackson Hole address to govt considering IBC committee recommendations

Aug 27, 2021

Here are the top news from the world of business, economics, national and international politics and more, handcrafted for you by the CNBC-TV18.com team.

Pay in crypto for your stay at this Swiss luxury hotel

Aug 27, 2021

The Swiss are well ahead in the crypto game with the town of Zug even known as 'Crypto Valley.' Now, the Chedi Andermatt in the Swiss Alps has made its tech statement. Prices start at 1300 francs/0.03 Bitcoin/0.45 Ethereum per night in the holiday season.

Freshworks CEO thanks 'Thalaivaa' Rajinikanth in IPO filing in US

Aug 28, 2021

Founder Girish Mathrubootham has penned a personal letter as part of the filing, speaking about the company's journey from a 700 ft warehouse in Chennai. In the postscript, Mathrubootham thanked the South Indian actor Rajinikanth.

Why 'nah he tweakin' comment by 'Satan Shoes' rapper set Instagram on fire?

Aug 26, 2021

Earlier this year Lil Nas X had released a limited run of 'Satan Shoes' that allegedly featured a drop of human blood. Nike in turn sued him and the company he had partnered with, following a huge backlash.